Taking note of the reality of the test market, the Council issued a series of recommendations to draw conclusions from the crisis linked to the pandemic. The study recommends reducing the dependence of the national market on global supply chains. This is all the more necessary as the national market is dominated by importers and distributors who generate more than 90% of its turnover. As an example, the Council refers to the market for COVID test reagents which, according to the report, has only one national manufacturer with a “100% Moroccan” product, and two manufacturers with manufacturing licenses of Korean origin. To strengthen the national productive fabric, the Council recommends a reference legislative framework for the marketing of “100% Moroccan” reagents and to promote innovation in the diagnostic test industry. The report also proposes to encourage the consumption of locally manufactured reagents.
Furthermore, for a more solid productive fabric, the Competition Council proposes an improvement in the governance of the drugs and medical devices sector. This is why the study pleads for the updating and operationalization of the platform for submitting registration applications. To do this, the establishment of the National Medicines Agency is essential.
The Council recalls that the contribution of private entities does not exceed 31% of the total tests carried out since the start of the pandemic at the end of 2021. For its part, the public sector has carried out 68% of PCR tests, including 40 % were insured by the Military Hospital
